EMA MR: long half life → MD [Design Issues]

posted by Loky do – Egypt, 2020-08-09 21:06 (911 d 09:42 ago) – Posting: # 21845
Views: 1,777

Thanks, Helmut your response always very helpful for us ;-)

Complete thread:

UA Flag
Activity
 Admin contact
22,481 posts in 4,710 threads, 1,603 registered users;
38 visitors (0 registered, 38 guests [including 16 identified bots]).
Forum time: 05:48 CET (Europe/Vienna)

The difference between a surrogate and a true endpoint
is like the difference between a cheque and cash.
You can get the cheque earlier but then,
of course, it might bounce.    Stephen Senn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5